La Administración Nacional de Productos Médicos aprueba Enhertu en China como el primer y único ADC dirigido a HER2 para el tratamiento de segunda línea de pacientes con cáncer gástrico metastásico HER2 positivo
La Administración Nacional de Productos Médicos aprueba Enhe…
1 month ago
marketscreener.com
ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens
ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Me…
Jan 5, 2021
businesswire.com
Explore the ENHERTU data | ENHERTU® (fam-trastuzumab deruxtecan-nxki) HCP
Explore the ENHERTU data | ENHERTU® (fam-trastuzumab der…
Aug 28, 2023
linkedin.com
Enhertu Copay Card Program: Affordable Treatment Options
Enhertu Copay Card Program: Affordable Treatment Options
Feb 6, 2025
cgaa.org
ENHERTU TV Spot, 'Digging Deeper'
ENHERTU TV Spot, 'Digging Deeper'
6 months ago
iSpot.tv
ENHERTU TV Spot, 'Not Today'
ENHERTU TV Spot, 'Not Today'
Sep 27, 2024
iSpot.tv
“Enhertu would be one of the drugs I would hopefully be able to access in the future. Our lives are worth it. We are worth it. That’s why we’ve come to have our stories heard, our questions answered, and to get this decision reversed.” - Viv Viv joined us in parliament yesterday at the All-Party Parliamentary Group on Breast Cancer’s roundtable meeting on Enhertu. It was a chance for her to share her views and experiences directly with NICE, NHS England, Daiichi Sankyo, and AstraZeneca. They hav
0:40
“Enhertu would be one of the drugs I would hopefully be able to acces…
6.6K viewsMay 9, 2024
FacebookBreast Cancer Now
Health Matters: New paper raises concern about breast-cancer screening guidelines
4:45
Health Matters: New paper raises concern about breast-cancer scre…
9.6K viewsJun 5, 2022
Global NewsCarla K. Johnson
Everything You Should Know About Enhertu for Breast Cancer
Everything You Should Know About Enhertu for Breast Cancer
6 months ago
health.com
Metastatic breast cancer: Enhertu stops the spread
1:47
Metastatic breast cancer: Enhertu stops the spread
Nov 13, 2022
wgem.com
Cancer du sein métastatique : l'Enhertu, un nouveau traitement porteur d'espoir
Cancer du sein métastatique : l'Enhertu, un nouveau traitement …
Sep 21, 2021
marieclaire.fr
Medical Moment: Enhertu stops the spread of metastatic breast cancer
1:51
Medical Moment: Enhertu stops the spread of metastatic breast cancer
Dec 6, 2022
wndu.com
Enhertu, es el nombre del nuevo medicamento de AstraZeneca, para personas con diagnóstico de cáncer de mama positivo, tanto especialistas como pacientes ven una esperanza de vida en dicho tratamiento. | Canal 11 TuTv
1:16
Enhertu, es el nombre del nuevo medicamento de AstraZeneca, par…
715 views10 months ago
FacebookCanal 11 TuTv
FDA Approves Enhertu for HER2-Positive Advanced Breast Cancer
FDA Approves Enhertu for HER2-Positive Advanced Breast Cancer
Dec 23, 2019
cancerhealth.com
Astra Zenecas Enhertu får genombrottsstatus i USA
Astra Zenecas Enhertu får genombrottsstatus i USA
3 months ago
di.se
Back in my healing chair for round 9 of Enhertu! Infused with extra joy gratitude today after such an epic experience speaking at ASCO in Chicago. May my miracle healing continue and yes, I look so stinkin CUTE today!😘💃😝 #livethefuckoutoflife xoxo, ❤️Bethany ________________________ CANCER THRIVER EVENTS: 🎀Free Mindset Young MBC Meetup: 6/11 🌱Grow Through What You Go Through: 6/19 🧘‍♀️Befriending Your Body: 8/6 🌀Mindset Coaching, Podcasts, Freebies, More #mbc #cancerthriver #metastaticbre
0:10
Back in my healing chair for round 9 of Enhertu! Infused with extra joy …
20.9K views9 months ago
FacebookBethany - My Guru Cancer
The antibody drug conjugate, #Enhertu, was approved for patients with unresectable or metastatic HER2-low or -ultralow #BreastCancer with disease progression after endocrine therapy. U.S. Food and Drug Administration #bcsm #Oncology https://www.curetoday.com/view/fda-approves-enhertu-for-her2-low-and--ultralow-breast-cancer | CURE Today
0:19
The antibody drug conjugate, #Enhertu, was approved for patie…
705 viewsFeb 7, 2025
FacebookCURE Today
Are you on trastuzumab deruxtecan (Enhertu) treatment?🤷‍♀️ Enhertu is an antibody-drug conjugate (ADC) used to treat certain types of metastatic breast cancer💊 It’s made up of👇 🔸Trastuzumab antibody: targets and binds to the HER2 protein in cancer cells 🔸Chemotherapy deruxtecan: enters the cancer cell, causing cell death☠️ 🔸Chemical linker: this binds the antibody and chemotherapy, and is cut by enzymes at cancer cells, releasing the deruxtecan drug Enhertu can cause difficult side effects
0:05
Are you on trastuzumab deruxtecan (Enhertu) treatment?🤷‍♀️ Enhertu i…
132 views2 months ago
FacebookOWise Breast Cancer
Enhertu: drug approved for advanced cancers – here’s what you need to know
Enhertu: drug approved for advanced cancers – here’s what y…
11 months ago
inkl.com
AstraZeneca : La valeur du jour en Europe Astrazeneca voit son Enhertu approuvé par Bruxelles contre le cancer gastrique avancé
AstraZeneca : La valeur du jour en Europe Astrazeneca voit son Enh…
Dec 19, 2022
zonebourse.com
An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer | CURE
An Expert Explains the Enhertu Approval in HER2-Low and -Ultral…
Feb 12, 2025
curetoday.com
Enhertu: drug approved for advanced cancers – here’s what you need to know
Enhertu: drug approved for advanced cancers – here’s what y…
10 months ago
theconversation.com
AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For HER2 Mutant Metastatic NSCLC
AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For …
Aug 12, 2022
nasdaq.com
Sanidad financiará Enhertu y Trodelvy, dos fármacos para tratar el cáncer de mama metastásico
0:23
Sanidad financiará Enhertu y Trodelvy, dos fármacos para trata…
Sep 26, 2024
Antena3.comRosario Miñano
SA cancer patient's plea to subsidize life-saving drugs
2:16
SA cancer patient's plea to subsidize life-saving drugs
Jan 31, 2023
7NEWSSowaibah Hanifie,Nathan Regter
Enhertu, medicamento de AstraZeneca vs. cáncer de mama, ayuda a pacientes a vivir más tiempo, según ensayo
Enhertu, medicamento de AstraZeneca vs. cáncer de mama, …
Feb 21, 2022
elfinanciero.com.mx
“For those of us living with HER2-low incurable secondary breast cancer, Enhertu is our first licensed targeted treatment. It offers us the hope of more time. “More time with our families. More time to make special memories. More time to do the things we loved. “It offered us a lifeline. But that lifeline has been snatched away. “NHS England, Daiichi Sankyo, Astra Zeneca and NICE - you have the power to give us back that lifeline.” Some of the incredible women campaigning for access to the drug
2:14
“For those of us living with HER2-low incurable secondary breast ca…
17.7K viewsJun 14, 2024
FacebookBreast Cancer Now
Daiichi Sankyo: ENHERTU Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy
Daiichi Sankyo: ENHERTU Approved in the EU as First HER2 …
11 months ago
finanznachrichten.de
Male breast cancer: Signs to watch for
3:43
Male breast cancer: Signs to watch for
4 months ago
The IndependentEleanor Fleming
New Hope for First-Line HER2+ Breast Cancer Treatment - Dr. Amy Krie Discusses Enhertu
1:10
New Hope for First-Line HER2+ Breast Cancer Treatment - Dr. Am…
121 views2 months ago
YouTubeOncology Exchange
See more